ID

34155

Description

Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01303419

Lien

https://clinicaltrials.gov/show/NCT01303419

Mots-clés

  1. 14/01/2019 14/01/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

14 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT01303419

Eligibility Breast Cancer NCT01303419

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
woman 21 years of age or older
Description

ID.1

Type de données

boolean

the subject is able and willing to comply with study procedures and signed and dated informed consent is obtained.
Description

ID.2

Type de données

boolean

newly diagnosed with breast cancer (dcis or invasive) identified through core biopsy or fine-needle aspiration (fna) within last 30 days.
Description

ID.3

Type de données

boolean

will have or have had a bilateral ce-bmri performed within 30 days after the new breast cancer diagnosis.
Description

ID.4

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
woman who has already had a lumpectomy for the index lesion.
Description

ID.5

Type de données

boolean

woman undergoing neoadjuvant chemotherapy treatment, hormone treatment or radiation therapy.
Description

ID.6

Type de données

boolean

woman who is pregnant or who believe she may be pregnant.
Description

ID.7

Type de données

boolean

woman who has breast implant.
Description

ID.8

Type de données

boolean

woman who has a contraindication to the intravenous use of iodinated or gadolinium-chelated contrast agent (e.g., allergy to either agent or severely impaired renal function).
Description

ID.9

Type de données

boolean

Similar models

Eligibility Breast Cancer NCT01303419

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
woman 21 years of age or older
boolean
ID.2
Item
the subject is able and willing to comply with study procedures and signed and dated informed consent is obtained.
boolean
ID.3
Item
newly diagnosed with breast cancer (dcis or invasive) identified through core biopsy or fine-needle aspiration (fna) within last 30 days.
boolean
ID.4
Item
will have or have had a bilateral ce-bmri performed within 30 days after the new breast cancer diagnosis.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
woman who has already had a lumpectomy for the index lesion.
boolean
ID.6
Item
woman undergoing neoadjuvant chemotherapy treatment, hormone treatment or radiation therapy.
boolean
ID.7
Item
woman who is pregnant or who believe she may be pregnant.
boolean
ID.8
Item
woman who has breast implant.
boolean
ID.9
Item
woman who has a contraindication to the intravenous use of iodinated or gadolinium-chelated contrast agent (e.g., allergy to either agent or severely impaired renal function).
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial